# Remdesivir Efficacy in Coronavirus Disease

> **NCT04345419** · PHASE2,PHASE3 · COMPLETED · sponsor: **Tanta University** · enrollment: 200 (actual)

## Conditions studied

- COVID

## Interventions

- **DRUG:** Remdesivir
- **OTHER:** Standard of care treatment

## Key facts

- **NCT ID:** NCT04345419
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-16
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2021-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04345419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04345419, "Remdesivir Efficacy in Coronavirus Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04345419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*